Intramuscular Olanzapine in the Management of Behavioral and Psychological Symptoms in Hospitalized Older Adults: A Retrospective Descriptive Study

Table 3

Documented adverse events and monitoring among cases that received olanzapine IM.

Adverse event	Number (%)
Sedation	7 (20.6%)
Orthostatic hypotension	5 (14.7%)
Falls	4 (11.8%)
Decreased level of consciousness	4 (11.8%)
Extrapyramidal symptoms	3 (8.8%)
Weakness	1 (2.9%)
Monitoring of vital signs (within 6 hrs)
Complete monitoring	42 (33.9%)
Incomplete monitoring	10 (8.1%)
No monitoring documented	58 (46.8%)
Patient refuses to comply	14 (11.2%)